Development of a Diagnostic Clinical Score for Hemodynamically Significant Patent Ductus Arteriosus
There is no consensus about the hemodynamic significance and, therefore, the need to treat a persistent ductus arteriosus in preterm newborns. Since the diagnosis of a hemodynamically significant persistent ductus arteriosus (hsPDA) is made by a summary of non-uniform echo-criteria in combination wi...
Saved in:
Main Authors: | Annemarie Kindler (Author), Barbara Seipolt (Author), Antje Heilmann (Author), Ursula Range (Author), Mario Rüdiger (Author), Sigrun Ruth Hofmann (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gentamicin in neonates with hemodynamically significant patent ductus arteriosus
by: Kannan Sridharan, et al.
Published: (2023) -
Controversy in the diagnosis and treatment of hemodynamically significant patent ductus arteriosus in preterm infants
by: Se In Sung
Published: (2019) -
Platelet Count Might Be Associated With the Closure of Hemodynamically Significant Patent Ductus Arteriosus
by: Junyan Zhong, et al.
Published: (2021) -
Antenatal Magnesium Sulfate Exposure and Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants
by: Amna Qasim, et al.
Published: (2019) -
Practice for preterm patent ductus arteriosus; focusing on the hemodynamic significance and the impact on the neonatal outcomes
by: Jin A Lee
Published: (2019)